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Abstract
Background: To determine the prevalence of abnormal findings on brain magnetic resonance
(MR) examinations in adult participants of brain docking in order to assess its usefulness.
Methods: We analyzed screening brain MR examinations for 1113 adults (age, 52.6+/-8.5 years;
range, 22–84; 761 male and 352 female) performed during 6-year period from April 1998 to March
2004. All participants voluntarily sought a brain MR examination at their own expense. All subjects
were studied using the same 1.0-T MR scanner, on axial T1-weighted spin echo (SE) images,
proton-density-weighted and T2-weighted fast SE images, and intracranial MR angiography (MRA).
All abnormal findings were classified into three basic categories: (1) findings with no referral
necessary; (2) findings not requiring further evaluation, but which needed to be reported to the
referring physician; (3) findings requiring further evaluation.
Results: Participants with abnormal MR findings requiring further evaluation accounted for 1.3 %,
but five of seven suspected intracranial aneurysms were not confirmed by other imaging modalities
(false positive). No malignant tumors or other life-threatening pathology was detected, and only
three participants (0.27 %) with abnormalities underwent surgical treatment. No participant groups
were identified from our data as being high risk for MR abnormal findings requiring further
evaluation.
Conclusion: Brain-docking participants had a variety of abnormalities on brain MR examinations,
but only a small percentage of these findings required further evaluation. The usefulness of the brain
docking with MRI and MRA has yet to be proven, and at this time we cannot approve this screening
procedure.
Background
"Brain docking", a method of screening for brain disease,
has become popular in Japan in recent years. This unique
Japanese practice, which may be performed as a part of an
annual medical check-up, usually consists of brain mag-
netic resonance (MR) imaging and MR angiography
(MRA) in addition to routine physical and laboratory
examinations. It has been believed that brain docking
may be beneficial for early diagnosis of some brain disor-
ders, since it is well established that unexpected abnor-
malities are sometimes detected on brain MR
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examinations, usually in the setting of an investigation for
a reason unrelated to the abnoramlity [1-4].
A screening examination is an examination on individuals
who are at risk for a particular disease or condition, but
who lack any signs or symptoms of the disease or condi-
tion, to determine if the disease or condition is present. It
should be done only when clinical studies have demon-
strated that screening examinations may do more good
than harm [5]. The extraordinary spatial resolution of MR
imaging seems to promise earlier intracranial disease
detection and improved patient outcomes. However, to
our knowledge, there has not been any scientific evidence
to demonstrate that a screening brain MR examination
may provide more benefit than harm to people being
screened. Screening studies may raise issues regarding
false-positive findings, overdiagnosis, and unnecessary
additional medical examinations when the result is falsely
interpreted as abnormal. Cost-effectiveness should also be
determined.
In the current study, we analyzed the results of screening
brain MR examinations in order to assess its usefulness.
We also attempted to identify participant groups which
are high risk for intracranial abnormalities on brain MR
examinations, as limiting the screened population to
those who are high risk for target disease would be better
for cost effectiveness.
Methods
Participants and clinical data
We included 1113 consecutive adult participants (age,
52.6+/-8.5 years; range, 22–84; 761 male and 352 female)
on whom brain MR examinations were performed during
6-year period from April 1998 to March 2004 as a part of
an annual medical check-up in our hospital. All partici-
pants voluntarily sought a brain MR examination at their
own expense. They usually believed that they were neuro-
logically healthy at the time of the medical check-up,
although some participants had a past history of brain inf-
arction, bleeding, trauma or tumor. Some of them had
recurrent headache or vertigo/dizziness, but they did not
feel that immediate medical advice was required.
All participants underwent a clinical interview, physical
and neurological examinations by a well-experienced
neurologist. The presence of recurrent or chronic head-
ache and vertigo/dizziness was always questioned by the
neurologist. Since vertigo and dizziness were not always
clearly differentiated, these two symptoms were com-
bined in our analyses. Participants' demographic data
consisted of age and sex. The body-mass-index (BMI), cal-
culated as weight/height2 (kg/m2), was used as the index
of relative weight. Self-reported data on cigarette smoking
were used to classify subjects as nonsmokers, current
smokers of 1 to 20 cigarettes per day (moderate smokers),
and those smoking more than 20 cigarettes per day (heavy
smokers). Regular alcohol consumption was recorded as
grams of average absolute ethanol per day, and catego-
rized as follows; nondrinkers, low alcohol intake (< 60 g/
day; moderate drinkers), and high alcohol intakes (≥ 60 g/
day; heavy drinkers). Individuals were considered to have
systemic hypertension if their blood pressure readings had
repeatedly exceeded 140 mmHg systolic or 90 mmHg
diastolic, if they were currently taking antihypertensive
therapy, or if they had a past medical history of systemic
hypertension. Diabetes mellitus was diagnosed by a fast-
ing serum glucose concentration of > 140 mg/dl or under
current treatment for diabetes. High serum cholesterol
level was diagnosed by a fasting serum total cholesterol
level of > 250 mg/dl, or having a past medical history of
high serum cholesterol level.
Brain stroke was defined as a history of physician-diag-
nosed symptomatic infarction and hemorrhage. Transient
ischemic attack (TIA) was not considered a brain stroke.
Cardiac diseases were defined as a history of congestive
heart failure, myocardial infarction, angina pectoris, left
ventricular hypertrophy, or atrial fibrillation; or electro-
cardiographic evidence of past myocardial infarction, left
ventricular hypertrophy, or atrial fibrillation.
MR imaging and interpretation
All participants were studied on the same 1.0-T MR scan-
ner (Magnex ®, Shimadzu, Kyoto, Japan), including axial
T1-weighted spin echo (SE; TR = 450 ms, TE = 15 ms), and
proton-density-weighted and T2-weighted fast SE (FSE; TR
= 4000 ms, TE = 20 and 100 ms, echo train length = 8)
images. The matrix was 256 * 192 and section thickness
was 5 mm with a gap of 2.5 mm for all sequences. MR ang-
iography (MRA) was also performed using time-of-flight
(TOF) technique (TR = 40 ms, TE = 9 ms, flip angle = 20°,
field of view = 200 mm; slice thickness = 1.0 mm; volume
thickness = 54 mm; matrix = 256 * 174; number of acqui-
sitions = 1; acquisition time = 6 minutes 15 seconds), and
16 projections of the MRA of the circle of Willis were cre-
ated by a maximum-intensity projection (MIP) algorithm
around the head-to-foot axis and right-to-left axis. Con-
trast-enhanced T1-weighted images were not obtained in
any cases.
All MR images were interpreted by a board-certified diag-
nostic radiologist (YT) with 17-years of experience as a
general radiologist, and all MR abnormalities were classi-
fied into three basic categories: (1) findings with no refer-
ral necessary; (2) findings not requiring further
evaluation, but which needed to be reported to the refer-
ring physician; (3) findings requiring further evaluation.
A well-experienced neurosurgeon also separately inter-
preted all images. When there was disagreement in imageBMC Neurology 2005, 5:18 http://www.biomedcentral.com/1471-2377/5/18
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interpretation and neutral consensus could not be
reached, the radiologist made the final decision. For MRA
image interpretation, only the MIP images were evaluated,
and the source images were not used.
White-matter signal abnormalities on MR images were
considered present if visible as high intensity on proton-
density and T2-weighted images, without prominent low
intensity on T1-weighted images. According to Fazekas
scale [6], periventricular hyperintensity (PVH) was graded
as 0 = absence, 1 = caps or pencil-thin lining, 2 = smooth
halo, and 3 = irregular PVH extending into the deep white
matter. Separate deep white matter high intensities
(DWMH) were rated as 0 = absent, 1 = punctuate foci, 2 =
beginning confluence of foci, and 3 = large confluent
areas. Both PVH and DWMH were considered abnormal
when the grades were 2 or 3 [6], and classified as a finding
not requiring further evaluation, but which needed to be
reported to the referring physician.
When an intracranial aneurysm was suspected on MRA, a
three-dimensional computed tomography (3D-CT) exam-
ination with contrast material or digital subtraction angi-
ography (DSA) was recommended to confirm the
diagnosis. 3D-CT was performed using a single-detector
helical CT scanner (HiSpeed ®, GE-Yokogawa, Tokyo,
Japan) with an intravenous bolus injection (2.5 ml/sec) of
contrast material (iopamidol, Iopamiron 370 ®, Nihon
Schering, Osaka, Japan; 80 ml), and surface rendering
(SR) images were constructed from 40 or 50 axial images
(thickness = 1.0 mm, pitch = 1.0) using an Advantage
Workstation ® (Version 3.1; GE-Yokogawa, Tokyo, Japan).
In our hospital, no approval of the ethics committee was
necessary for this kind of a retrospective study. The Decla-
ration of Helsinki principles was followed.
Statistical analyses
The data were expressed by mean +/- standard deviation
(SD). For statistical analyses, Student t test and Fisher
exact test were used. P values less than 0.05 were consid-
ered significant. We set the screening cost for MR exami-
nation at US$200, although we know that the cost is
much higher in US and EU countries.
Results
Nine of 1113 participants had a past history of intracra-
nial disease or trauma (two with cerebral bleedings, two
with infarctions, two with brain contusions, one subdural
hematoma [postoperative], one acoustic neurinoma
[postoperative] and one intracranial aneurysm [oper-
ated]). Of 1113 participants, 939 (84.4 %) were catego-
rized was having no abnormal findings or findings with
no referral necessary. Abnormal MR findings were demon-
strated in 15.6 % of the participants and were classified as
follows: 159 (14.3 %) with findings not requiring further
evaluation, but needed to be reported to the referring phy-
sician; 15 (1.3 %) with findings requiring further evalua-
tion (Table 1,2). No malignant tumors or other life-
threatening pathology were detected.
On MRA, seven intracranial aneurysms and one middle
cerebral artery stenosis in eight participants were sus-
pected (Table 1), and all were categorized as having find-
ings requiring further evaluation. Of these eight
participants, one aneurysm of the anterior communicat-
ing artery (8 mm) and a middle cerebral artery stenosis
were confirmed by 3D-CT. Five presumed aneurysms, all
of which were measured less than 5 mm in diameter on
MRA, were not confirmed on 3D-CT (n = 2) or DSA (n =
3), thus we considered that the MRA findings of these five
participants were to be false positives. These false positive
findings were suspected to be due to the low image quality
of the MRA images. One remaining participant did not
Table 1: Findings requiring further evaluation (15 participants, 
1.3%).
MR diagnosis No. of cases
Aneurysm, confirmed 1
Aneurysm, unconfirmed 6
Arachinoid cyst in the quadrigerminal plate cistern 1
Pituitary adenoma 3
Meningioma 1
Epidermoid tumor 1
Superficial siderosis 1
Major vessel stenosis 1
Total 15
Table 2: Findings not requiring further evaluation, but needing to 
be reported to the referring physician (159 participants, 14.3%).
MR diagnosis No. of cases
White-matter signal abnormalities 113
Lacunar infarction 31
Old lobar or cerebellar infarction 13
Venous malformation 6
Arachinoid cyst in the middle cranial fossa 4
Old bleeding 4
Old traumatic lesion 2
Cerebral atrophy 2
Total 175BMC Neurology 2005, 5:18 http://www.biomedcentral.com/1471-2377/5/18
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wish to confirm the diagnosis of aneurysm on other imag-
ing modalities.
In our screened population, three participants (0.27%)
with abnormalities (one aneurysm, one pituitary ade-
noma and one epidermoid tumor) underwent surgical
treatment.
Demographic and clinical data of the participants were
summarized in Table 3. There were no statistically signifi-
cant differences between the participants with and with-
out abnormal MR findings requiring further evaluation.
The cost for a screening brain MR examination was
approximately US$200 in Japan, thus the estimated cost
for the identification of one participant with a finding
requiring further evaluation (1.3 %) was US$ 14840.
When the cases with unconfirmed intracranial aneurysms
were excluded, there were nine participants who had find-
ings requiring further evaluation, and the cost for the
identification of one participant with a finding requiring
further evaluation (0.8 %) rose to US$ 24733.
Discussion
In the current study, a variety of abnormal findings was
discovered on screening brain MR examinations, but most
of them were not serious. The prevalence of the abnormal
findings requiring further evaluation in our study was
only 1.3 %, and no malignant tumors or other life-threat-
ening pathology was detected in any participants.
Some studies have attempted to determine the prevalence
of abnormal findings in screening brain MR examina-
tions, although most of these prior reports have focused
on some specific abnormalities, such as silent infarctions
[7], brain tumors [8] and unruptured intracranial aneu-
rysms [9]. For instance, Onizuka et al. [8] reviewed screen-
ing brain MR examinations of 4000 individuals (24–85
years; mean, 56.0) without neurological signs or symp-
toms. They have focused on the prevalence of brain
tumors, and found 11 incidental brain tumors (0.28 %).
Some studies (Table 4) reported the prevalence of various
incidental findings on MR examinations in neurologically
healthy individuals in the setting of an investigation for
other reasons [1-4]. Katzmen et al. [2] enrolled 1000 vol-
unteers (3–83 years; mean, 30.6) who participated as con-
trol subjects for various research protocols, and reported
the prevalence of 1.1 % of routine referral and 0 % of
immediate referral necessary. Kim et al. [3] retrospectively
reviewed 225 MR examinations performed for various
research purposes in neurologically healthy children (1
month -18 years; mean 11.2 years), and reported a single
lesion (< 1 %) requiring urgent referral. The prevalence of
abnormal findings requiring further evaluation in our
study (1.3 %) was close to the results previously reported
in the adult population [1,2,4]. A very small percentage of
participants (three participants; 0.27%) with abnormal
findings required surgery in our study, and Yue et al. [1]
also reported a similar low prevalence for abnormalities
requiring surgery (0.25%).
Table 3: Demographic and clinical data of the participants with and without abnormal MRI findings requiring further evaluation.
Variables Findings requiring further evaluation (n = 15) No abnormality or findings not requiring further 
evaluation (n = 1098)
Age range Total Age range Total
34–59 y.o. (n = 11) 60–84 y.o. (n = 4) 34–59 y.o. (n = 910) 60–84 y.o. (n = 188)
Age (y.o.) 54.3 +/- 10.0 52.5 +/- 8.5
(range) (34–75) (22–84)*
Sex, male:female 9:2 1:3 10:5 622:288 129:59 751:347§
BMI (kg/m-2) 24.5 +/- 4.9 23.7 +/- 0.7 24.3 +/- 4.1 23.6 +/- 3.7 23.5 +/- 3.0 23.6 +/- 3.7
(range) (19.5–35.6) (22.7–24.4) (19.5–35.6) (13.8–59.0) (13.8–33.5) (13.8–59.0)*
Hypertension 3 1 4 (26.7%) 204 (22.4%) 59 (31.3%) 263 (24.0%)§
Diabetes mellitus 1 0 1 (6.7%) 94 (10.3%) 37 (19.7%) 131 (11.9%)§
Hyperlipidemia 6 1 7 (46.7%) 279 (30.7%) 74 (39.4%) 353 (32.0%)§
Cardiac disease 0 0 0 (0.0%) 21 (2.3%) 15 (8.0%) 36 (3.3%)§
Heavy smoking 1 0 1 (6.7%) 114 (12.5%) 16 (8.5%) 130 (11.8%)§
Heavy drinker 0 0 0 (0.0%) 40 (4.4%) 2 (1.1%) 42 (3.8%)§
Headache 1 0 1 (6.7%) 125 (13.7%) 9 (4.8%) 134 (12.2%)§
Vertigo/Dizziness 4 0 4 (26.7%) 111 (12.2%) 24 (12.8%) 135 (12.3%)§
There were no statistically significant differences between the participants with and without abnormal MR findings requiring further evaluation (*, 
Student t test; §, Fisher exact test). No statistics were done on the breakdowns (age range) of each group.BMC Neurology 2005, 5:18 http://www.biomedcentral.com/1471-2377/5/18
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It was quite difficult to determine the cost effectiveness of
brain docking, since a variety of intracranial diseases were
discovered. It would be better to calculate quality-
adjusted life-years (QALYs) gained by this screening pro-
cedure but this was also difficult for the same reason.
From our study, however, since no malignant tumors or
other life-threatening diseases (except for an aneurysm)
were discovered in any participants, the cost-effectiveness
of this screening procedure would largely depend on the
prevalence of intracranial aneurysms. However, the wis-
dom of searching for and treating small asymptomatic
intracranial aneurysms has been widely questioned.
Yoshimoto et al. [10] reported that screening asympto-
matic populations to identify and treat unruptured aneu-
rysms would not be cost-effective assuming the incidence
of unruptured aneurysm of 3.0 % in 50-year-old subjects
and annual rupture rates of 0.02–0.005. In the current
study, the prevalence of a possible intracranial aneurysm
was only 0.62 % (seven of 1113 participants), and only
one aneurysm was surgically treated, thus based on their
study it was less likely that the screening brain MR exami-
nation was cost-effective in our population. Baba et al.
[11] also studied the cost-effectiveness of screening for
asymptomatic unruptured intracranial aneurysms and
concluded that such a mass screening was not cost-effec-
tive unless the diagnostic accuracy of MRA was
considerably increased or the annual rate of subarachi-
noid hemorrhage due to unruptured aneurysms was high
(0.01 to 0.02 per year). The diagnostic accuracy of intrac-
ranial aneurysms affects the usefulness of screening MRA.
It has been reported that MRA can depict intracranial
aneurysms 5 mm or larger with good accuracy [12]. How-
ever, MRA is less useful for the identification of smaller
aneurysms, and the accuracy in the detection of intracra-
nial aneurysms depends on the field strength, i.e. high
field strength confers higher accuracy [13]. The develop-
ment of both hardware and software of the MR unit also
contributes to the improvement in the accuracy of the
detection of intracranial aneurysms. The field strength of
our MR unit used in this study was 1.0 T and both hard-
ware and software were relatively old, so many small
aneurysms may have escaped a correct diagnosis on the
MRA in the current study. For a better understanding of
the false positive aneurysms it is better to make compari-
sons to newer MR technologies, although it is quite diffi-
cult to discuss this issue only from our current data.
Further studies using newer MR equipments are encour-
aged, and we are now trying to evaluate MRA images in
the brain docking in our hospital using new 1.5-T MR
equipment.
Not only MRA but also brain MRI may miss some condi-
tions, and a diagnosis of normal might be inaccurate.
However, it was less likely that the field strength of the MR
unit and the quality of hardware and software would sig-
nificantly affect the accuracy of detecting clinically impor-
tant intracranial abnormalities on MRI, since findings less
conspicuous than those detected in our study were
unlikely to be clinically important. The lack of clinical fol-
low-up, which may result in the underestimation of false
negative findings, was also a shortcoming of our study.
Currently, the false negative rate of brain docking is
unknown.
Another important concern was that the diagnoses of
uncertain or unimportant findings may require additional
invasive testing or elaborate follow-up, which may place
the persons at risk for unexpected health consequences
and lead them to unwarranted health expenditures, and
will result in increased patient anxiety [14]. In fact in the
current study, five of seven presumed intracranial aneu-
rysms were not confirmed by other imaging modalities.
Table 4: The studies evaluating the frequency of clinically important abnormalities on head MRI in neurologically normal participants 
of research protocols.
Study & Year No. of 
participants 
(male/female)
Mean age 
(range)
MRI results
No referral* Routine 
referral
Urgent 
referral
Immediate 
referral
Yue NC, et al. (1997) (1) 3672 > 65 3608 (98.3 %) 64 (1.7 %)
Katzman GL, et al. (1999) (2) 1000 (546/454) 30.6 (3–83) 971 (97.1 %) 18 (1.8 %) 11 (1.1 %) 0 (0 %)
Kim BS, et al. (2002) (3) 225 (100/125) 11.2 (0–18) 206 (91.6 %) 17 (8 %) 1 (< 1 %) 0 (0 %)
Illes J, et al. (2004) (14) 151 (82/69) 47.1 (18–90) 141 (93.4 %) 7 (4.6 %) 3 (2.0 %) 0 (0 %)
SD: standard deviation.
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From the view point of cost-effectiveness, it is better to
limit the screened population who are at high risk for the
target diseases. However, we were not able to identify any
groups which were high risk for having intracranial MR
abnormalities requiring further evaluation.
Conclusion
Brain-docking participants had a variety of abnormalities
on brain MR examinations, but the percentage of these
findings requiring further evaluation was small. The use-
fulness of the brain docking with MRI and MRA has yet to
be proven, and at this time we cannot approve this screen-
ing procedure.
Competing interests
The author(s) declare that they have no competing
interests.
Authors' contributions
YT participated in the design of the study and performed
the statistical analysis. KE and ATT conceived of the study,
and participated in its design and coordination and
helped to draft the manuscript. All authors read and
approved the final manuscript.
References
1. Yue NC, Longstreth WT Jr, Elster AD, Jungreis CA, O'Leary DH,
Poirier VC: Clinically serious abnormalities found incidentally
at MR imaging of the brain: data from the Cardiovascular
Health Study.  Radiology 1997, 202:41-46.
2. Katzman GL, Dagher AP, Patronas NJ: Incidental findings on brain
magnetic resonance imaging from 1000 asymptomatic
volunteers.  JAMA 1999, 282:36-39.
3. Kim BS, Illes J, Kaplan RT, Reiss A, Atlas SW: Incidental findings on
pediatric MR images of the brain.  AJNR Am J Neuroradiol 2002,
23:1674-1677.
4. Illes J, Rosen AC, Huang L, Goldstein RA, Raffin TA, Swan G, Atlas
SW:  Ethical consideration of incidental findings on adult
brain MRI in research.  Neurology 2004, 62:888-890.
5. Hillman BJ: CT screening: who benefits and who pays.  Radiology
1993, 228:26-28.
6. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR sig-
nal abnormalities at 1.5 T in Alzheimer's dementia and nor-
mal aging.  AJR 1987, 149:351-356.
7. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S: Subcorti-
cal silent brain infarction as a risk factor for clinical stroke.
Stroke 1997, 28:1932-1939.
8. Onizuka M, Suyama K, Shibayama A, Hiura T, Horie N, Miyazaki H:
Asymptomatic brain tumor detected at brain check-up.  Neu-
rol Med Chir (Tokyo) 2001, 41:431-435.
9. Nakagawa T, Hashi K: The incidence and treatment of asymp-
tomatic, unruptured cerebral aneurysms.  J Neurosurg 1994,
80:217-223.
10. Yoshimoto Y, Wakai S: Cost-effectiveness analysis of screening
for asymptomatic, unruptured intracranial aneurysms: a
mathematical model.  Stroke 1999, 30:1621-1627.
11. Baba Y, Takahashi M, Korogi Y: Cost-effectiveness of screening
unruptured cerebral aneurysms in Japan.  Eur Radiol 2000,
10(Suppl 3):S362-S365.
12. Korogi Y, Takahashi M, Mabuchi N, Miki H, Fujiwara S, Horikawa Y,
Nakagawa T, O'Uchi T, Watabe T, Shiga H: Intracranial aneu-
rysms: diagnostic accuracy of three-dimensional, Fourier
transform, time-of-flight MR angiography.  Radiology 1994,
193:181-186.
13. Korogi Y, Takahashi M, Mabuchi N, Watabe T, Shiokawa Y, Shiga H,
O'Uchi T, Nakagawa T, Miki H, Horikawa Y, Fujiwara S, Furuse M:
MR angiography of intracranial aneurysms: a comparison of
0.5 T and 1.5 T.  Comput Med Imag Graph 1997, 21:111-116.
14. Illes J, Fan E, Koenig BA, Raffin TA, Kann D, Atlas SW: Self-referred
whole-body CT imaging: current implications for health care
consumers.  Radiology 2003, 228:346-351.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2377/5/18/prepub